EFFECT OF ZOLEDRONIC ACID ON PERIPROSTHETIC BONE LOSS AFTER NON CEMENTED PRIMARY TOTAL HIP ARTHROPLASTY. A QUANTITATIVE ANALYSIS USING DXA

被引：0
|
作者：
Nieto, E. [3 ]
Uzcategui, J. [1 ]
Salinas, J. [4 ]
Mendoza, J. [2 ]
机构：
[1] Univ Hosp, Merida, Venezuela
[2] Univ Los Andes, Merida, Venezuela
[3] Inst Clin Med Quirurg, Merida, Venezuela
[4] Inst Osteoporosis & Densitometria Osea, Merida, Venezuela
来源：
OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [1] Effect of zoledronic acid on periprosthetic bone loss after non cemented primary total hip arthroplasty. A quantitative analysis using DXA
    Nieto, E. J.
    Uzcategui, J. E.
    Salinas, J. R.
    Mendoza, J. L.
    BONE, 2009, 44 (02) : S429 - S430
  • [2] EFFECT OF ZOLEDRONIC ACID ON PERIPROSTHETIC BONE LOSS AFTER NON CEMENTED PRIMARY TOTAL HIP ARTHROPLASTY. A QUANTITATIVE ANALYSIS USING DXA
    Nieto, E.
    Uzcategui, J.
    Salinas, J.
    Mendoza, L.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 124 - 124
  • [3] The effect of a single zoledronic acid 5 mg on periprosthetic bone loss after non cemented primary total hip arthroplasty A quantitative analysis using DXA
    Nieto, E. J.
    Uzcategui, J. E.
    Saavedra, D. J.
    Salinas, J. R.
    BONE, 2011, 48 : S162 - S163
  • [4] Periprosthetic bone mineral density of cemented total hip arthroplasty.
    Albanese, CV
    Ruschioni, V
    Ghera, S
    Santori, F
    Francone, L
    Passariello, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S464 - S464
  • [5] Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study
    Nehme, A
    Maalouf, G
    Tricoire, JL
    Giordano, G
    Chiron, P
    Puget, J
    REVUE DE CHIRURGIE ORTHOPEDIQUE ET REPARATRICE DE L APPAREIL MOTEUR, 2003, 89 (07): : 593 - 598
  • [6] Alendronate treatment prevents periprosthetic bone loss following total hip arthroplasty.
    Blake, GM
    Rahmy, AIA
    Tonino, A
    Fogelman, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S441 - S441
  • [7] A SINGLE DOSE OF ZOLEDRONIC ACID PREVENTS PERIPROSTHETIC BONE LOSS IN FEMALE PATIENTS WITH CEMENTLESS TOTAL HIP ARTHROPLASTY
    Aro, Hannu T.
    Moritz, Niko
    Timlin, Satu
    Lankinen, Petteri
    Svedstrom, Erkki
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S295 - S295
  • [8] Low bone density is a major risk factor for periprosthetic bone loss following total hip arthroplasty.
    Blake, GM
    Rahmy, AIA
    Tonino, AJ
    Tan, WD
    Fogelman, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S313 - S313
  • [9] Pamidronate prevents periprosthetic bone loss after total hip arthroplasty
    Wilkinson, JM
    Stockley, I
    Peel, NFA
    Hamer, AJ
    Elson, RA
    Barrington, NA
    Eastell, R
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S27 - S27
  • [10] Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
    Hsu, Allen Herng Shouh
    Yen, Chun-Hsien
    Kuo, Feng-Chih
    Wu, Cheng-Ta
    Huang, Tsan-Wen
    Cheng, Juei-Tang
    Lee, Mel S.
    PHARMACEUTICALS, 2022, 15 (04)
12345